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ABSTRACT
Introduction: There is little awareness of venous
thromboembolism (VTE) in the public arena. Most
commonly known causes are—travellers’ thrombosis
and thrombosis associated with oral contraception,
both frequently referred to in the media. However, VTE
is a substantial healthcare problem, resulting in
mortality, morbidity and economic cost. Most
hospitalised patients have one or more risk factors for
VTE. Around 60% of people undergoing hip or knee
replacement will suffer a deep vein thrombosis without
preventative intervention. Studies demonstrate a risk
reduction for VTE of up to 70% with preventative
medicine for medical and surgical conditions: cancer,
orthopaedic surgery, general surgery and acutely ill
medical admissions. Results will be used to identify
methods of increasing knowledge of VTE prevention
and for the development of educational and patient
information materials.
Methods and analysis: A two-stage, mixed-method
study using surveys with primary healthcare
professionals and patients followed by interviews with
primary healthcare professionals, patients, acute trusts
and other relevant organisations. Survey and qualitative
interview data will examine the current practice of
thromboprophylaxis, and the knowledge and
experience of VTE prevention for the development of
education initiatives for primary healthcare
professionals and patients to adopt
thromboprophylaxis outside the hospital setting. As
this is a scientific exploratory study for the generation,
rather than testing, of new hypotheses a sample-size
analysis is not called for. Survey data will be analysed
using SPSS version 20. Open-ended responses will be
analysed using qualitative thematic methods. The
recorded and transcribed semistructured interview data
will be analysed using constant comparative methods.
Ethics and dissemination: Ethics approval has been
provided by the National Research Ethics Committee
(reference: 11/H0605/5) and site-specific R&D approval
granted by the relevant R&D National Health Service
trusts. Findings will be disseminated at healthcare and
academic conferences and written for peer-reviewed
publication.
Trial grant number: NIHR RP-PG-0608-10073
INTRODUCTION
There is little awareness of venous thrombo-
embolism (VTE) in the public arena.1 The
most commonly known causes are travellers’
thrombosis and its association with oral
contraception, both frequently referred to in
the media. These, however, are uncommon
causes of thrombosis compared to the risk
associated with hospital admissions for either
medical or surgical conditions.1 Most hospi-
talised patients have one or more risk factors
for VTE.2–6 Mortality owing to VTE after hos-
pital admission is more than 10 times the
number caused by Staphylococcus aureus
(MRSA, methicillin-resistant S aureus) and is
greater than the combined total of deaths
from breast cancer, AIDS and road trafﬁc
incidents each year in the UK.7 Public ignor-
ance is not surprising when healthcare pro-
fessionals also underestimate the extent of
ARTICLE SUMMARY
Article focus
▪ Understanding the current practice of thrombo-
prophylaxis, and the knowledge and experience
of venous thromboembolism (VTE) prevention.
▪ Study protocol using a mixed-methods approach.
Key messages
▪ VTE is a largely unrecognised as a significant
healthcare problem.
▪ Public and healthcare professionals underestimate
the extent of VTE for hospital admissions.
Educational and patient information materials will
be developed to adopt thromboprophylaxis outside
of the hospital setting.
Strengths and limitations of this study
▪ Survey and interview data from multiple sources
will provide a unique insight into the knowledge
of, and barriers facing, VTE prevention.
▪ Workplace demands may limit the response from
healthcare professionals.
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VTE.8 Thus, VTE is a substantial healthcare problem,
resulting in signiﬁcant mortality, morbidity and eco-
nomic cost.9 In 2005 VTE was estimated by the Health
Select Committee to cost the National Health Service
(NHS) £640 million a year to manage.
There is evidence to show that around 60% of people
undergoing hip or knee replacement will suffer a deep
vein thrombosis (DVT) without preventative interven-
tion9 and that DVT has a mortality rate of 30% when left
untreated.1 Figures from numerous studies also demon-
strate a risk reduction for VTE of up to 70% for medical
and surgical conditions: cancer, orthopaedic surgery,
general surgery and acutely ill medical admissions.10 11
As a result, in April 2007 National Institute for Health
and Clinical Excellence (NICE) published a clinical
guideline offering best-practice advice for reducing the
risk of VTE in inpatients undergoing high-risk surgery
and latterly for all surgical procedures.12 13 The Chief
Medical Ofﬁcer also announced the publication of a VTE
risk assessment tool recommended for all patients admit-
ted to hospital in England14 (19 September 2008). New
NICE guidelines were introduced in January 2010 cover-
ing all patients aged 18 years and over admitted to hos-
pital (including day patients).15 The guidelines include
medical, surgical and cancer patients and recommend
risk assessment for VTE and risk of bleeding be under-
taken for all patients at admission (and repeated after
24 h) and appropriate prophylaxis be provided where
indicated.15 Further, the Royal College of Obstetricians
and Gynaecologists produced a Green-top Guideline
regarding the prevention of VTE during pregnancy, birth
and following delivery.16 In addition, VTE is one of the
four Quality Standards to be developed by NICE. These
standards offer quality measures such as the number of
patients aged 18 years and more who have been admitted
to a hospital and the number who received a VTE assess-
ment.17 The standards are also used for the basis of
Commissioning for Quality and Innovation (CQUIN)
agreements with trusts and as from June 2010 the
CQUIN payment framework requires all acute trusts in
the UK to risk assess 90% of patients admitted for VTE to
receive 1.5% for their funding. Finally, the Care Quality
Commission is responsible for monitoring the trusts’ per-
formance on the new Quality Standards throughout the
UK and will be collecting data each month on VTE risk
assessments as well as visiting the trusts and interviewing
staff of their performance.
Alongside these initiatives, an All Parliamentary
Thrombosis Group (APPTG) undertook a survey of 173
acute NHS hospital trusts in 2007 to elucidate awareness
of the problem and the action being taken. The survey
found that implementation was poor despite almost uni-
versal awareness of the guidance.18 The survey demon-
strated that only one-third of the hospital trusts were
implementing mandatory risk assessments on every
patient admitted, another one third were educating
patients on admission and discharge and the remaining
one third were educating the staffs regarding
thromboprophylaxis. A further APPTG survey in 2008
showed a marked improvement with 70% of trusts now
stating they were undertaking risk assessment on all
patients. However, this means that one third of trusts are
still not assessing the risk in a structured manner. The
survey also showed that patient information around the
risk factors for VTE is poor. This survey was superceded
in 2010 and found a continued low general awareness of
VTE. The report called for a VTE public awareness cam-
paign. In addition, the majority of trusts were unable to
provide monthly data on the percentage of patients at
risk of VTE who received appropriate prophylaxis.19
The APPTG reports suggested that there is a role for
primary care trusts (PCTs) and that patient and public
education will play an important role. Primary healthcare
professionals are in a good position to deliver VTE educa-
tion to patients and empower patients with the knowledge
to request a risk assessment on admission to hospital.
However, we do not know patients’ attitudes towards edu-
cation and information. Will highlighting the need for
thromboprophylaxis to patients result in a reduction in
events or will it have an unfavourable clinical outcome?
A study in 2007 of 460 patients, used a standardised ques-
tionnaire to determine patients’ preferences to consent to
low-molecular-weight-heparin (LMWH) prophylaxis follow-
ing an orthopaedic surgery.20 The patients were educated
concerning the risk of heparin-induced thrombocytopenia
(HIT) with LMWH. (HIT is a life-threatening, immune-
mediated prothrombotic adverse drug effect that occurs
less often with LMWH than with unfractionated heparin in
orthopaedic surgery patients). Patients appreciated receiv-
ing information about the potential adverse effects of
heparin prophylaxis. The speciﬁc information about HIT
did not lead to treatment refusal with all patients chosing
to receive the drug. Over 90% of patients welcomed the
information and felt it appropriate to be informed.
When considering patient barriers to VTE prophylaxis,
diabetes studies have shown the desire to avoid inject-
able drugs and LMWH therapy may therefore introduce
concordance issues.21 Healthcare professional barriers
to initiating VTE prophylaxis may be manifold.
Knowledge-to-practice translation issues are extremely
important for the successful integration of thrombopro-
phylaxis into the community.
There is little evidence to suggest that care pathways
are always successful for disease management. A
Cochrane review of in-hospital care pathways stated that
there was insufﬁcient evidence to support their routine
implementation, no reduction in hospital length of stay
was seen.22 A further evaluating pathways for chronic
obstructive airway disease, congestive cardiac failure,
myocardial infarction and pneumonia had similar con-
clusions.23 There has been no evidence of the use of
care plans for prophylaxis in the community. However,
one study evaluated a heart failure programme of care
in the community using an integrated multidisciplinary
team and an educational package for patients including
advice on disease recognition and compliance.24 This
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study had more positive outcomes in terms of decreased
length of stay in hospital and readmission rates.
STUDY RATIONALE
VTE is a recognised risk following inpatient admission.
However, with appropriate thromboprophylaxis, risk of
VTE can be reduced by up to 70% for medical and sur-
gical conditions. In January 2010, new NICE guidelines
were introduced which recommend VTE risk assessment
of all patients aged 18 years and over who are admitted
to hospital. The new initiatives introduced by the depart-
ment of health focus on monitoring the risk assessment
for VTE in the hospital setting and will document the
performance of the hospital trusts. There is a need to
transfer awareness, education and management of
thromboprophylaxis outside the hospital setting.
Currently there is a gap in our knowledge about the
role of primary care in thromboprophylaxis. We do not
know what information high-risk patients receive prior
to hospital admission or what happens to them when
they return to the community.
This study will assess current levels of knowledge of VTE
risk and current practice of thromboprophylaxis among
the range of primary healthcare professionals and
patients. This will identify barriers to the implementation
of thromboprophylaxis in primary care. Based on these
data, effective educational measures will be designed for
implementation outside the hospital setting to ensure
patients receive the most effective care to prevent VTE.
METHODS
Study aims and objectives
The overriding aim of the study is to explore the existing
knowledge and perceived role of primary care in throm-
boprophylaxis among primary healthcare professionals,
patients, acute trusts and relevant organisations for the
development of educational initiatives to help the adop-
tion of safe practices outside the hospital setting. This
will include the identiﬁcation of barriers to providing
thromboprophylaxis in primary care. The study objec-
tives are as follows:
▸ To assess the level of existing knowledge of VTE risk
among a range of primary healthcare professionals
and patients;
▸ To assess current practice and the perceived role of
primary care in thromboprophylaxis among primary
healthcare professionals and patients;
▸ To explore the interface between primary and sec-
ondary care in terms of thromboprophylaxis and the
perceived role of primary care among acute trusts
and other relevant organizations;
▸ To explore potential care pathways for high-risk
patients prior to hospital admission in terms of assess-
ment for thromboprophylaxis;
▸ To design effective education initiatives to ensure
public and primary care engagement in VTE pre-
ventative measures outside the hospital setting.
STUDY DESIGN
This two-stage, mixed-method study will involve surveys
with primary healthcare professionals and patients fol-
lowed by interviews with primary healthcare profes-
sionals, patients, acute trusts and relevant organisations,
for example, Lifeblood and Anticoagulation Europe,
both charities involved in supporting patients with
thromboembolic disease.
INFORMED CONSENT
All potential participants will be provided with a partici-
pant information sheet. Primary healthcare professionals
completing the postal survey will be asked to complete a
written consent form as part of the survey. All profes-
sionals taking part in an interview will be asked to com-
plete a written consent form prior to the interview.
All potential patients will be provided with a partici-
pant information sheet and consent form either while
on the ward or at discharge. All patients will be given at
least 24 h to decide whether they would be willing to
participate. The participant information sheet will
include contact telephone numbers of the research
team who will be available to answer any questions.
Willing participants will sign two copies of the consent
form, one copy of which they will retain.
The participant information sheet has been written
for ease of understanding and checked for readability
using The Flesch-Kincaid Grade Level readability score
(8.3) and Flesch Reading Ease Test (64.5). The patient
consent form will ask permission to contact patients’
general practitioners (GPs) and the Information Centre
for Health and Social Care. Interviewed patients will
complete an additional consent form prior to the
interview.
STAGE 1: SURVEY
The development of the survey was informed by pub-
lished research and the previous work carried out by the
research team.
Practitioners and practice nurses
A postal survey, containing open and closed questions,
will be sent to all of the GPs (n=728) and practice
nurses (PNs) (n=440) in Oxfordshire and South
Birmingham PCTs.
This stage will be used to generate information on
their knowledge of VTE risk and thromboprophylaxis,
the current use of VTE risk assessment and thrombopro-
phylaxis and information on the education that is cur-
rently provided on risk and management of VTE both in
terms of the education healthcare professionals receive
and the education they provide. The survey will deter-
mine current and potential care pathways and examine
any perceived ﬁnancial or clinical barriers to the use of
VTE risk assessment and management and the impact
on workload in terms of resources for undertaking the
risk assessment and providing education to patients and
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other healthcare professionals as well as undertaking the
thromboprophylaxis procedure. Topics in the survey
include
▸ Awareness of the guidance into prevention of VTE;
▸ Methods of prophylaxis currently adopted;
▸ Advice currently given to patients with regard to
thromboprophylaxis before admission to hospital;
▸ Opinions of how to improve thromboprophylaxis
implementation.
In the survey participants will be asked if they would
be willing to participate in a face-to-face interview and a
sample will be approached for in-depth interviews.
High-risk patients
A postal survey, using open and closed questions, will be
conducted with a sample of high-risk patients (n=600)
from Oxfordshire and Birmingham acute trusts. Fifty
per cent of the sample will be patients requiring
extended thromboprophylaxis (deﬁned using the
department of health risk assessment tool). This is a sci-
entiﬁc exploratory study for the generation, rather than
testing, of new hypotheses. Accordingly, no sample-size
analysis is called for. Differing demographic variables
will be used to look for patterns of response and to
examine associations among the variables. Given the
exploratory nature of this study, the sample sizes
included are thought to be acceptable for drawing pre-
liminary conclusions about the prevention and knowl-
edge of VTE.
The survey will examine patients’ receipt of informa-
tion and education about risk of VTE and need for
thromboprophylaxis prior to hospital admission and will
assess their awareness of VTE risk and attitudes to receiv-
ing thromboprophylaxis, their experiences of risk assess-
ment for VTE and of thromboprophylaxis during
hospital admission and at discharge. In addition, the
survey will evaluate the contact that those patients’ on
extended thromboprophylaxis have with primary health-
care professionals following discharge from hospital.
Eligibility criteria
Inclusion criteria
▸ Patients assessed as being at high risk of VTE (requir-
ing or not requiring extended prophylaxis) aged
18 years and over admitted to the identiﬁed wards.
Exclusion criteria
▸ Patients unable to speak/read English;
▸ Patients unable or unwilling to provide informed
consent;
▸ Patients not assessed to be at high risk of venous
thromboembolism;
▸ High-risk patients admitted to wards other than those
identiﬁed for the study.
Recruitment of patients
The patients will be recruited in medical, surgical and
orthopaedic wards from acute trusts in Oxfordshire and
Birmingham. Potential patients will be approached by a
research nurse while on the ward postsurgery. The
research nurse will discuss the study with potential
patients and provide a patient information sheet (PIS).
Patients will be given at least 24 h to decide whether
they would be willing to participate. They will then have
the opportunity to further discuss the study with the
research nurse who will revisit them on the ward. They
can also contact the research team for information. If
patients are willing to participate they will be asked to
sign two copies of the consent form, one copy of which
they will retain and one copy for the research team.
Patients who are to be discharged within 24 h will be
provided with information packs (PIS, 2 consent forms
and prepaid envelope). These patients will be asked to
return one copy of the consent form, in the envelope
provided, within 2 weeks. The research nurse will inform
the research team when consenting patients are dis-
charged. The research nurse will keep a record of all
patients approached to calculate response rates and will
maintain an anonymised log of the patients who have
been issued with the information packs. Upon receipt of
the consent form, the research team will immediately
send a survey and a further prepaid envelope to those
patients not requiring extended prophylaxis. High-risk
patients requiring extended prophylaxis will be sent the
survey pack to their home address to arrive 28 days after
discharge. Topics covered in the patient survey include
details of hospital admission, knowledge of thrombosis
risk before admission, knowledge and management of
thrombosis risk during admission, knowledge and man-
agement of thrombosis risk at the end of hospital stay,
management of thrombosis risk following hospital stay,
the patient’s understanding of information given and
personal details.
Patients will be asked to indicate on the survey if they
would be interested in taking part in an interview. A
sample of those indicating interest in the interviews will
then be approached for recruitment to the in-depth
interviews.
Stage 2
Interviews
The surveys of primary healthcare professionals and
high-risk patients will elicit broad concepts and issues
which will be developed and explored in more detail in
the subsequent interviews.
Interviews with primary healthcare professionals
In-depth semistructured telephone or face-to-face inter-
views will be undertaken with a purposive sample of
approximately 60 GPs and PNs who respond to the
survey. The sampling will take into account individual
responder characteristics and important issues identiﬁed
in the survey. In addition, pharmacy leads and PCT com-
missioners will be identiﬁed for interview to be followed
by snowball sampling.25 26 This will involve identifying a
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key informant in each organisation and asking them to
recommend other appropriate people for interview.
Topics to be covered in the interview schedule will
include
▸ An examination of current practice and existing
knowledge of VTE;
▸ Potential care pathways for high-risk patients prior to
hospitalisation;
▸ Management of VTE in primary care;
▸ Identiﬁcation of barriers to managing VTE in the
community;
▸ An exploration of the interface between primary and
secondary care.
The option of a telephonic interview or online inter-
view will be offered. An appropriate sample is composed
of participants who best represent or have knowledge of
the research topic.25 26 Our sample will have sufﬁcient
knowledge of the research topic to allow the data to
reach saturation. Saturation is reached when data is gath-
ered to the point of diminishing returns and nothing
new is being added27 no new insights are obtained, no
new themes are identiﬁed and no issues arise regarding
a category of data.28 At this point, the data categories
are considered well established and validated. Saturation
of each category signiﬁes the stage at which to end the
research.29 Saturation is derived from a coherent and
rigorous process of data condensation and interpretation
that accounts for all possible explanations.30 Clear
descriptions of the data saturation process, and the
forms in which it was recognised during the analysis, will
be provided in the research reports as suggested by
Caelli et al.31
Interviews with high-risk patients
Face-to-face semistructured interviews with a purposive
sample of 30 high-risk patients (across the two PCTs)
who respond to the survey will be undertaken. 50% of
which will be patients requiring extended thrombopro-
phylaxis. Individual characteristics such as age, gender,
ethnicity and medical condition will be taken into
account when sampling. The interviews will explore
topics elicited from the initial survey and will be carried
out at a place of the patient’s choice. The interviews’
schedule topics will include
▸ Patient awareness of VTE;
▸ Satisfaction with VTE information and understanding
of the information received;
▸ Adherence to treatment;
▸ The need for primary care intervention;
▸ Issues to increase awareness of VTE.
The interview schedule will be reviewed by two layper-
sons to ensure suitability.
Interviews with acute trusts and other relevant organisations
Interviews will be conducted with a purposive sample of
staff in the four acute trusts including ward managers in
medical, surgical and orthopaedic wards, consultants and
registrars and a sample of people in relevant organisations
such as the Lifeblood Charity and Anticoagulation
Europe. These interviews will explore the interface
between primary and secondary care in terms of VTE pre-
vention and the perceived role of primary care. Areas to
be covered in the interview schedule will include
▸ The role and current use of VTE risk assessment and
thromboprophylaxis in primary care;
▸ An examination of interdisciplinary communication;
▸ Perceived barriers to VTE management;
▸ Training provision and future requirements for VTE
management.
Key informants will be identiﬁed to be followed by
snowball sampling.25 26 The sample is expected to
include between 10 and 30 participants.
Care pathways
Potential care pathways for high-risk patients admitted to
hospital will be explored as well as effective education
initiatives to enhance public and primary healthcare
engagement in VTE prevention. The care pathway will
be devised utilising data received from the survey and
interviews with both primary healthcare professionals
and patients. It will comprise a guide for primary health-
care professionals to assess patients at high risk of VTE,
guidance on how to integrate management of thrombo-
prophylaxis between hospital and the community.
Educational resources for both primary healthcare pro-
fessionals and patients will be produced to give informa-
tion and education for patients before and after
admission to hospital, with particular reference to com-
pliance and disease recognition.
The purpose of the care pathway devised in this body
of work will be to provide a mechanism to coordinate
care, reduce fragmentation and educate primary health-
care professionals and patients which will ultimately
reduce costs by preventing VTE. The whole package of
care plus educational resources will be evaluated in a
future randomized-controlled trial.
Data analysis
Survey data will be analysed using SPSS. Descriptive data
will be summarised from the two surveys. Open-ended
responses will be analysed using qualitative thematic
methods. The recorded and transcribed semistructured
interview data will be analysed using constant compara-
tive methods developed by Glaser.32 The constant com-
parative method utilises the skills and sensitivities of the
analyst to assist theory generation which is integrated,
consistent, plausible and close to the data. Themes and
patterns are identiﬁed from the data, rather than being
imposed on the data and are presented in a clear
manner that allows ﬂexibility to aid the creative gener-
ation of theory. The method uses theory and empirical
data as means of creating hypothesis and a deeper
understanding of the phenomena being researched.33
Data collection and analysis will be iterative occurring as
data collection in the interviews’ proceeds, with new data
being used to challenge and assess or conﬁrm emerging
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analysis. Key categories and concepts emerging from each
of the three interview groups will be considered individu-
ally for each group, across the dimensions selected for pur-
posive sampling within groups, between groups where
there are areas of communality and across established con-
cepts in existing literature.
Study outcomes
Primary outcome
▸ An understanding of the perceived role of primary
care in thromboprophylaxis prevention and manage-
ment and an awareness of the knowledge of thrombo-
prophylaxis among primary healthcare professionals,
patients, acute trusts and other relevant organisations.
Secondary outcomes
▸ An understanding of the current practice of thrombo-
prophylaxis among primary healthcare professionals
and patients;
▸ Development of education initiatives for primary
healthcare professionals and patients to adopt throm-
boprophylaxis outside of the hospital setting;
▸ Knowledge of the perceived and actual clinical bar-
riers to thromboprophylaxis;
▸ Development of care pathways for high-risk patients
prior to hospital admission.
DISCUSSION
The results of the surveys and interviews in conjunction
with the pathways analysis will inform the design of
optimal awareness and educational interventions for VTE
prophylaxis. The results will help clinicians understand
the barriers to thromboprophylaxis and will identify
methods of increasing knowledge of VTE prevention to
primary healthcare professionals needing to educate
patients preadmission and postadmission to hospital and
as such, through the use of appropriate care pathways and
education, to reduce costs by preventing readmission to
hospital for recurrence of VTE. The combined results of
the surveys and interviews in conjunction with the path-
ways analysis will inform the design of optimal awareness
and educational interventions for VTE prophylaxis.34
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